To our knowledge, we are the first who evaluated PD-L1+ lymphocyte distribution in tumour tissue in the context of the TME (CD4+ T cells, Foxp3+CD4+ T cells, IL17A+CD4+ T cells, CD8+ T cells, M1 and M2 macrophages). The gene discussed is IL17A; the disease is neoplasm.